IL6 and malnutrition: Indeed, given the coexistence and reciprocal influence of inflammation and malnutrition risk in these patients, the use of the CONUT score, in combination with other markers such as PhA and/or IL-6, could be a relevant tool for a more rapid and reliable assessment of patient’s status and disease outcomes in the clinical setting.